LH Action in Ovarian Cell Differentiation

LH 在卵巢细胞分化中的作用

基本信息

  • 批准号:
    8495779
  • 负责人:
  • 金额:
    $ 34.61万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1982
  • 资助国家:
    美国
  • 起止时间:
    1982-03-01 至 2014-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Ovulation is the unique biological process by which a mature oocyte and surrounding cumulus cells, comprising the cumulus cell-oocyte complex (COC), are released from the surface of the ovary. This LH-induced process is similar to an inflammatory response and requires the expression of specific genes: the EGF-like factors (Areg, Ereg, Btc), matrix factors (Has2, Ptgs2, Tnfaip6, Ptx3) and cytokines (Il6). AREG potently activates ERK1/2, COC expansion, oocyte maturation and IL6 production in cultured COCs. However, the genes regulated specifically by AREG/ERK1/2 and the consequences of disrupting these signaling molecules in vivo have not been determined. Therefore, using Erk1 (Erk1-/-) null mice, Erk2fl/fl mice and mice expressing Cre driven by the aromatase (Cyp19) promoter, we have generated Erk1/2 double KO (Erk1-/- ;Erk2fl/fl/;Cyp19-Cre) mice. Follicular development is normal but preovulatory follicles fail to ovulate and COC expansion is impaired in the Erk1/2 double KO mice. In addition to inflammation-related genes, LH/AREG also regulate the expression of specific genes that comprise the innate-immune cell surveillance response system, including the Toll-like receptors TLR2 and TLR4 and components of this system (C1q, Cd14, and Pdcd1) uniquely expressed in cumulus cells. TLR2 and TLR4 are functional in cumulus cells and respond to known ligands (including matrix factors) leading to the production of IL6 that can induce COC expansion in culture in the absence of AREG or PGE. Preliminary data indicate that Tlr4-/- mice are subfertile. By analyzing the signaling cascades and the expression of specific genes in Erk1/2 double KO mice and in mice null for the Areg target genes (Tlr/42, Ptx3 and Pdcd1) that are expressed in COCs, we should be able to dissect and delineate a novel genetic program that controls cumulus cell function and ovulation. Because the production of cytokines, including IL6, appears to be critical for ovulation, we propose that the ERK1/2 pathway controls an endocrine-immune-cytokine regulatory network during ovulation. Therefore we propose these specific aims: Specific Aim I: Determine the molecular mechanisms by of ERK2 (MAPK1) and ERK1 (MAPK3) regulate granulosa cell and cumulus cell functions and ovulation in vivo. Test the hypothesis that ERK1/2 mediate specific effects of LH induced ovulation and cumulus cell function. Specific Aim II: Determine the function of AREG (ERK1/2) target genes that are uniquely expressed at high levels in ovulated COCs and that impact ovulation. Test the hypotheses that specific matrix factors, IL6 and innate immune cell-related genes expressed in cumulus cells direct the unique fate of these cells.
描述(申请人提供):排卵是一种独特的生物过程,成熟的卵母细胞和周围的卵丘细胞,组成卵丘细胞-卵母细胞复合体(COC),从卵巢表面释放出来。促黄体生成素诱导的这一过程类似于炎症反应,需要特定基因的表达:EGF样因子(Areg、Ereg、BTC)、基质因子(Has2、Ptgs2、Tnfaip6、Ptx3)和细胞因子(IL6)。AREG能有效地激活培养的COCs的ERK1/2、COC扩增、卵母细胞成熟和IL6的产生。然而,AREG/ERK1/2特异调控的基因以及体内干扰这些信号分子的后果尚未确定。因此,利用ERK1(ERK1-/-)缺失小鼠、Erk2fl/fl小鼠和芳香酶(Cyp19)启动子驱动表达Cre的小鼠,我们获得了ERK1/2双KO(ERK1-/-;Erk2fl/fl/;Cyp19-Cre)小鼠。ERK1/2双KO小鼠卵泡发育正常,但排卵前卵泡无法排卵,COC扩张受损。除了炎症相关基因,黄体生成素/AREG还调节组成天然免疫细胞监视反应系统的特定基因的表达,包括Toll样受体TLR2和TLR4以及该系统的组件(C1q、CD14和Pdcd1)在卵丘细胞中唯一表达。TLR2和TLR4在卵丘细胞中发挥作用,并对已知的配体(包括基质因子)做出反应,导致IL6的产生,在没有AREG或PGE的情况下,IL6可以在培养中诱导COC扩张。初步数据表明,TLR4-/-小鼠是不育的。通过分析ERK1/2双KO小鼠和在COC中表达的Areg靶基因(TLR/42、Ptx3和Pdcd1)缺失的小鼠的信号级联和特定基因的表达,我们应该能够解剖和描绘控制卵丘细胞功能和排卵的新的遗传程序。由于包括IL6在内的细胞因子的产生似乎对排卵至关重要,我们认为ERK1/2途径在排卵过程中控制着内分泌-免疫-细胞因子调节网络。因此,我们提出了这些特定的目的:特定目的I:确定ERK2(MAPK1)和ERK1(MAPK3)在体内调节颗粒细胞和卵丘细胞功能和排卵的分子机制。验证ERK1/2介导促黄体生成素诱导排卵和卵丘细胞功能的特异性效应的假设。特定目的II:确定AREG(ERK1/2)靶基因的功能,这些基因在排卵的COCs中唯一高水平表达,并影响排卵。测试在卵丘细胞中表达的特定基质因子、白介素6和先天免疫细胞相关基因决定这些细胞独特命运的假设。

项目成果

期刊论文数量(42)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Hormone induction of progesterone receptor (PR) messenger ribonucleic acid and activation of PR promoter regions in ovarian granulosa cells: evidence for a role of cyclic adenosine 3',5'-monophosphate but not estradiol.
  • DOI:
    10.1210/mend.12.8.0157
  • 发表时间:
    1998-08
  • 期刊:
  • 影响因子:
    0
  • 作者:
    J. W. Clemens;R. Robker;W. Kraus;B. Katzenellenbogen;J. Richards
  • 通讯作者:
    J. W. Clemens;R. Robker;W. Kraus;B. Katzenellenbogen;J. Richards
Tyrosine kinase inhibitor AG18 arrests follicle-stimulating hormone-induced granulosa cell differentiation: use of reverse transcriptase-polymerase chain reaction assay for multiple messenger ribonucleic acids.
酪氨酸激酶抑制剂 AG18 阻止卵泡刺激素诱导的颗粒细胞分化:使用逆转录酶聚合酶链反应测定多种信使核糖核酸。
  • DOI:
    10.1210/endo.134.6.7514996
  • 发表时间:
    1994
  • 期刊:
  • 影响因子:
    4.8
  • 作者:
    Orly,J;Rei,Z;Greenberg,NM;Richards,JS
  • 通讯作者:
    Richards,JS
Gonadotropin-induced expression of pancreatitis-associated protein-III mRNA in the rat ovary at the time of ovulation.
排卵时大鼠卵巢中促性腺激素诱导的胰腺炎相关蛋白 III mRNA 表达。
  • DOI:
    10.1677/joe.0.1740485
  • 发表时间:
    2002
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Yoshioka,S;Fujii,S;Richards,JS;Espey,LL
  • 通讯作者:
    Espey,LL
Rat cholesterol side-chain cleavage cytochrome P-450 (P-450scc) gene. Structure and regulation by cAMP in vitro.
大鼠胆固醇侧链裂解细胞色素 P-450 (P-450scc) 基因。
Rapid induction of prostaglandin endoperoxide synthase in rat preovulatory follicles by luteinizing hormone and cAMP is blocked by inhibitors of transcription and translation.
黄体生成素和 cAMP 在大鼠排卵前卵泡中快速诱导前列腺素内过氧化物合酶被转录和翻译抑制剂阻断。
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JoAnne Stewart Richards其他文献

JoAnne Stewart Richards的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JoAnne Stewart Richards', 18)}}的其他基金

Novel Aspect of Androgen Action in Ovarian Cell Function and Dysfunction
雄激素在卵巢细胞功能和功能障碍中作用的新方面
  • 批准号:
    10172961
  • 财政年份:
    2019
  • 资助金额:
    $ 34.61万
  • 项目类别:
Novel Aspect of Androgen Action in Ovarian Cell Function and Dysfunction
雄激素在卵巢细胞功能和功能障碍中作用的新方面
  • 批准号:
    10415947
  • 财政年份:
    2019
  • 资助金额:
    $ 34.61万
  • 项目类别:
Novel Aspect of Androgen Action in Ovarian Cell Function and Dysfunction
雄激素在卵巢细胞功能和功能障碍中作用的新方面
  • 批准号:
    10640129
  • 财政年份:
    2019
  • 资助金额:
    $ 34.61万
  • 项目类别:
Novel Aspect of Androgen Action in Ovarian Cell Function and Dysfunction
雄激素在卵巢细胞功能和功能障碍中作用的新方面
  • 批准号:
    10006016
  • 财政年份:
    2019
  • 资助金额:
    $ 34.61万
  • 项目类别:
Steroid Hormones Regulate Ovarian Cancer Progression and Metastasis
类固醇激素调节卵巢癌的进展和转移
  • 批准号:
    8923209
  • 财政年份:
    2014
  • 资助金额:
    $ 34.61万
  • 项目类别:
Steroid Hormones Regulate Ovarian Cancer Progression and Metastasis
类固醇激素调节卵巢癌的进展和转移
  • 批准号:
    9538594
  • 财政年份:
    2014
  • 资助金额:
    $ 34.61万
  • 项目类别:
Mechanisms Controlling Divergent Fates of Ovarian Follicles and Fertility
控制卵巢卵泡和生育力不同命运的机制
  • 批准号:
    8694652
  • 财政年份:
    2014
  • 资助金额:
    $ 34.61万
  • 项目类别:
Mechanisms Controlling Divergent Fates of Ovarian Follicles and Fertility
控制卵巢卵泡和生育力不同命运的机制
  • 批准号:
    9273274
  • 财政年份:
    2014
  • 资助金额:
    $ 34.61万
  • 项目类别:
Mechanisms Controlling Divergent Fates of Ovarian Follicles and Fertility
控制卵巢卵泡和生育力不同命运的机制
  • 批准号:
    9527155
  • 财政年份:
    2014
  • 资助金额:
    $ 34.61万
  • 项目类别:
Mechanisms Controlling Divergent Fates of Ovarian Follicles and Fertility
控制卵巢卵泡和生育力不同命运的机制
  • 批准号:
    9070506
  • 财政年份:
    2014
  • 资助金额:
    $ 34.61万
  • 项目类别:

相似国自然基金

运动对骨骼肌 Aromatase/17β-estradiol 通路的影响及功能研究
  • 批准号:
    19ZR1452900
  • 批准年份:
    2019
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目

相似海外基金

Targeting Sphingosine-1-phosphate (S1P1) receptors for the treatment of Aromatase Inhibitors-induced Musculoskeletal Symptoms
靶向 1-磷酸鞘氨醇 (S1P1) 受体治疗芳香酶抑制剂引起的肌肉骨骼症状
  • 批准号:
    10668781
  • 财政年份:
    2023
  • 资助金额:
    $ 34.61万
  • 项目类别:
Post-translational regulation of aromatase in aging
衰老过程中芳香酶的翻译后调控
  • 批准号:
    10976001
  • 财政年份:
    2023
  • 资助金额:
    $ 34.61万
  • 项目类别:
Post-translational regulation of aromatase in aging
衰老过程中芳香酶的翻译后调控
  • 批准号:
    10572625
  • 财政年份:
    2023
  • 资助金额:
    $ 34.61万
  • 项目类别:
Neuroanatomical substrates underpinning brain aromatase control of feeding behavior and metabolic homeostasis
支持大脑芳香酶控制摄食行为和代谢稳态的神经解剖学基质
  • 批准号:
    10737130
  • 财政年份:
    2023
  • 资助金额:
    $ 34.61万
  • 项目类别:
Comprehensive multi-omic analyses of "islands of resistance" tumour cells to identify aromatase inhibitor resistant subclones in ER+ breast cancer
对“耐药岛”肿瘤细胞进行全面的多组学分析,以鉴定 ER 乳腺癌中芳香酶抑制剂耐药的亚克隆
  • 批准号:
    2893229
  • 财政年份:
    2023
  • 资助金额:
    $ 34.61万
  • 项目类别:
    Studentship
Web-based Pain Coping Skills Training to Improve Pain and Poor Adherence caused by Aromatase Inhibitor-Associated Arthralgia In Breast Cancer Survivors (SKIP-Arthralgia): A Randomized Controlled Trial
基于网络的疼痛应对技能培训,以改善乳腺癌幸存者芳香酶抑制剂相关关节痛引起的疼痛和依从性差(SKIP-关节痛):一项随机对照试验
  • 批准号:
    10439192
  • 财政年份:
    2022
  • 资助金额:
    $ 34.61万
  • 项目类别:
Web-based Pain Coping Skills Training to Improve Pain and Poor Adherence caused by Aromatase Inhibitor-Associated Arthralgia In Breast Cancer Survivors (SKIP-Arthralgia): A Randomized Controlled Trial
基于网络的疼痛应对技能培训,以改善乳腺癌幸存者芳香酶抑制剂相关关节痛引起的疼痛和依从性差(SKIP-关节痛):一项随机对照试验
  • 批准号:
    10630101
  • 财政年份:
    2022
  • 资助金额:
    $ 34.61万
  • 项目类别:
A reciprocal relationship between alcohol and the p450 enzyme aromatase
酒精和 p450 芳香酶之间的相互关系
  • 批准号:
    10681419
  • 财政年份:
    2021
  • 资助金额:
    $ 34.61万
  • 项目类别:
Inflammatory oxylipins and aromatase inhibitor toxicity in breast cancer
乳腺癌中的炎性氧脂素和芳香酶抑制剂毒性
  • 批准号:
    10178172
  • 财政年份:
    2021
  • 资助金额:
    $ 34.61万
  • 项目类别:
A reciprocal relationship between alcohol and the p450 enzyme aromatase
酒精和 p450 芳香酶之间的相互关系
  • 批准号:
    10386167
  • 财政年份:
    2021
  • 资助金额:
    $ 34.61万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了